Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 May;82(5):e28-e30.
doi: 10.1016/j.jinf.2021.01.023. Epub 2021 Feb 3.

Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study

Fabio Borgonovo  1 , Matteo Passerini  2 , Marco Piscaglia  2 , Valentina Morena  2 , Andrea Giacomelli  3 , Letizia Oreni  4 , Gianfranco Dedivitiis  4 , Angelica Lupo  3 , Stefania Falvella  5 , Maria Vittoria Cossu  4 , Amedeo F Capetti  3
Affiliations
Observational Study

Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study

Fabio Borgonovo et al. J Infect. 2021 May.
No abstract available

PubMed Disclaimer

Figures

Fig. 1:
Fig. 1
Anti S antibody persistence overtime. ○ mean/outliers of Anti-S antibody titres at T1 by severity groups; + mean/outliers of Anti-S antibody titres at T2 by severity groups; x mean/outliers of Anti-S antibody titres at T3 by severity groups.
See this image and copyright information in PMC

Comment on

References

    1. Hanrath A.T., Payne B.A., Duncan C.J. Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection. 2020. doi:10.1016/j.jinf.2020.12.023 - PMC - PubMed
    1. Why decoding the immune response to COVID matters for vaccines. Nature. 2020;586(7830):473–474. doi: 10.1038/d41586-020-02943-9. - DOI - PubMed
    1. LIAISON Ⓡ SARS-CoV-2 S1/S2 IgG The fully automated serology test for the detection of SARS-CoV-2 IgG Antibodies. https://www.diasorin.com/sites/default/files/allegati/liaisonr_sars-cov-....pdf (accessed on 20 Jan, 2021)
    1. Kim D.S., Rowland-Jones S., Gea-Mallorquí E. Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? implications for vaccine strategies (2020) Front Immunol. 2020;11 doi: 10.3389/fimmu.2020.571481. - DOI - PMC - PubMed
    1. Clinical Management of COVID-19. https://www.who.int/publications/i/item/clinical-management-of-covid-19. https://www.who.int/publications/i/item/clinical-management-of-covid-19 (accessed on 20 Jan, 2021)

Substances